Karyo Biologics at Festival of Biologics 2026

Oct 13–15, 2026 Basel, Switzerland ~3k attendees Website

Karyo Biologics takes part in 2 sessions at Festival of Biologics 2026 in Basel. Its program centres on biosimilars, from the rules for approving them to bringing them to market. The key topic is the FDA's move to drop clinical efficacy studies for monoclonal antibody biosimilars.

OrganizationFestival of Biologics 2026 Attendance
karyobio.com
Biotech
Develops and licenses biosimilars, with commercial sponsors funding development costs.
Talk
Tue Oct 13
14:10
Panel
Wed Oct 14
15:10
Biosimilars Market Access & Commercialisation
Market Access and Market Sustainability · with BL Consulting, Bio-Thera Solutions

Explore the full Festival of Biologics 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Basel. Leave your work email and we’ll be in touch.

Privacy

Download the full Festival of Biologics 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Karyo Biologics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the Festival of Biologics. Submit a correction